MedPath

To compare which drug works better in treatment of plaque psoriasis between 2 percent crisaborole cream vs 0.1 percent betamethasone valereate ointment.

Phase 3
Conditions
Health Condition 1: L400- Psoriasis vulgaris
Registration Number
CTRI/2024/08/072562
Lead Sponsor
GURUPRAKASH A V
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient clinically diagnosed as Psoriasis vulgaris with less than 10 percent Body Surface Area involvement.

2.Age above 12 years

3. Patient willing for consent , study and follow up.

4. Patient willing to take clinical photos.

5. Patient not on any other treatment with topical and systemic drugs for Psoriasis for at least past 1 month.

Exclusion Criteria

1.Patients below 12 years.

2.Patients with Psoriasis involving more than 10 percent Body Surface Area.

3.Patients with Severe Psoriasis Vulgaris and Erythrodermic Psoriasis, Pustular Psoriasis, Guttate Psoriasis, Nail Psoriasis, Psoriatic Arthritis.

4.Patients who are on treatment with topical or systemic drugs specific to Psoriasis within past 1 month.

5.Patients with active infection at the study site.

6.Patient not willing for regular follow-up or to take clinical pictures.

7.Lactating or Pregnant women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath